RadNet, Inc. Increase Decrease In Operating Lease Liability
RadNet, Inc. (RDNT) reported Increase Decrease In Operating Lease Liability of -$29.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-10
- RadNet, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$15.94M.
- RadNet, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$13.30M.
- RadNet, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$14.06M.
- RadNet, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$14.03M.
- RadNet, Inc. increase decrease in operating lease liability for fiscal 2025 was -$62.82M.
- RadNet, Inc. increase decrease in operating lease liability for fiscal 2024 was -$54.87M.
- RadNet, Inc. increase decrease in operating lease liability for fiscal 2023 was -$54.76M.
- RadNet, Inc. increase decrease in operating lease liability for fiscal 2022 was -$68.94M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$15.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$29.24M 10-Q · filed 2026-08-10 | -$43.29M derived: sum of 3 quarters · filed 2026-08-10 | -$57.33M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$13.30M 10-Q · filed 2026-05-11 | -$27.36M derived: sum of 2 quarters · filed 2026-05-11 | -$41.39M derived: sum of 3 quarters · filed 2026-05-11 | -$54.15M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$14.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$28.09M derived: sum of 2 quarters · filed 2026-03-02 | -$40.85M derived: sum of 3 quarters · filed 2026-08-10 | -$62.82M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$14.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$26.79M derived: sum of 2 quarters · filed 2026-08-10 | -$48.76M 10-Q · filed 2025-11-10 | -$63.13M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$12.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$34.73M 10-Q · filed 2026-08-10 | -$49.09M derived: sum of 3 quarters · filed 2026-08-10 | -$61.88M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$21.97M 10-Q · filed 2026-05-11 | -$36.34M derived: sum of 2 quarters · filed 2026-05-11 | -$49.13M derived: sum of 3 quarters · filed 2026-05-11 | -$63.95M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | -$14.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$27.16M derived: sum of 2 quarters · filed 2026-03-02 | -$41.98M derived: sum of 3 quarters · filed 2026-03-02 | -$54.87M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$12.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$27.61M derived: sum of 2 quarters · filed 2025-11-10 | -$40.50M 10-Q · filed 2025-11-10 | -$51.87M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$14.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$27.71M 10-Q · filed 2025-08-11 | -$39.08M derived: sum of 3 quarters · filed 2026-03-02 | -$53.89M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$12.88M 10-Q · filed 2025-05-12 | -$24.26M derived: sum of 2 quarters · filed 2026-03-02 | -$39.06M derived: sum of 3 quarters · filed 2026-03-02 | -$52.57M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | -$11.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$26.18M derived: sum of 2 quarters · filed 2026-03-02 | -$39.68M derived: sum of 3 quarters · filed 2026-03-02 | -$54.76M 10-K · filed 2026-03-02 |
| 2023-09-30 | -$14.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$28.31M derived: sum of 2 quarters · filed 2024-11-12 | -$43.39M 10-Q · filed 2024-11-12 | -$62.74M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$13.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$28.58M 10-Q · filed 2024-08-09 | -$47.93M derived: sum of 3 quarters · filed 2025-03-03 | -$65.31M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$15.08M 10-Q · filed 2024-05-10 | -$34.43M derived: sum of 2 quarters · filed 2025-03-03 | -$51.80M derived: sum of 3 quarters · filed 2025-03-03 | -$68.16M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$19.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$36.72M derived: sum of 2 quarters · filed 2025-03-03 | -$53.08M derived: sum of 3 quarters · filed 2025-03-03 | -$68.94M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$17.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$33.74M derived: sum of 2 quarters · filed 2023-11-09 | -$49.60M 10-Q · filed 2023-11-09 | -$67.11M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$16.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$32.22M 10-Q · filed 2023-08-09 | -$49.74M derived: sum of 3 quarters · filed 2024-02-29 | -$68.21M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$15.86M 10-Q · filed 2023-05-10 | -$33.38M derived: sum of 2 quarters · filed 2024-02-29 | -$51.85M derived: sum of 3 quarters · filed 2024-02-29 | -$70.12M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$17.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$35.99M derived: sum of 2 quarters · filed 2024-02-29 | -$54.26M derived: sum of 3 quarters · filed 2024-02-29 | -$72.55M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$18.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$36.74M derived: sum of 2 quarters · filed 2022-11-09 | -$55.03M 10-Q · filed 2022-11-09 | -$65.59M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$18.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$36.56M 10-Q · filed 2022-08-09 | -$47.12M derived: sum of 3 quarters · filed 2023-03-01 | -$60.29M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$18.29M 10-Q · filed 2022-05-10 | -$28.85M derived: sum of 2 quarters · filed 2023-03-01 | -$42.02M derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | -$10.55M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$23.72M derived: sum of 2 quarters · filed 2023-03-01 | -$53.91M 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$13.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$43.35M 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$30.18M 10-Q · filed 2021-08-09 | |||
| 2019-12-31 | -$66.83M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |